Home » Topics » BioWorld Science, Hematologic

BioWorld Science, Hematologic
RSS

Roberts seeks European approval of Agrylin

July 11, 1997

ReoPro effective in baboon models of human renal disorders

July 11, 1997

Factor Xa inhibitors from Berlex

July 11, 1997

Outcome in unstable angina improved with ReoPro

July 8, 1997

Novel antiplatelet agent from Cypress Bioscience

July 4, 1997

Effects of thrombin inhibitor with or without gpIIb/IIIa antagonist during coronary thrombolysis

July 3, 1997

Topical t-PA for the treatment of venous ulcers

July 2, 1997

Synthesis and pharmacological profile of new antithrombotic pentasaccharide

July 2, 1997

Cell Genesys reports encouraging preclinical results of gene therapy for hemophilia

July 1, 1997

ReoPro safe and effective in high-risk PTCA patients

July 1, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 22, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...